OR WAIT null SECS
August 16, 2022
In this episode of the Drug Solutions Podcast, John Koleng, VP of product development and manufacturing for TFF Pharmaceuticals shares outsourcing strategies in biopharma.
June 02, 2022
The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the basics for maintaining an acceptable working relationship between a client and their CDMO.
April 03, 2022
Experts discuss what data to consider when selecting a high-potential drug candidate and how AI can be harnessed in medicinal chemistry drug discovery.
February 01, 2022
Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
January 21, 2022
Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.
January 03, 2022
A new focus on speed to market creates challenges for facility design and construction.
November 19, 2021
Sterling Pharma Solutions has announced a £10 million (US$13.5 million) investment into process development and manufacturing capacity at its site in Dudley, UK.
October 15, 2021
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, which doubles production capacity to support commercial and industrial manufacturing of viral vectors.